about
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer TherapyStructural characterization of the apo form and NADH binary complex of human lactate dehydrogenaseHeterogeneity of glycolysis in cancers and therapeutic opportunities.Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cellsProgrammed cell death induced by (-)-8,9-dehydroneopeltolide in human promyelocytic leukemia HL-60 cells under energy stress conditionsSynthesis and biological evaluation of non-glucose glycoconjugated N-hydroyxindole class LDH inhibitors as anticancer agents.Dichloroacetate Decreases Cell Health and Activates Oxidative Stress Defense Pathways in Rat Alveolar Type II PneumocytesLactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and deathSalicylketoximes That Target Glucose Transporter 1 Restrict Energy Supply to Lung Cancer CellsThe Hybrid Pyrroloisoindolone-Dehydropyrrolizine Alkaloid (-)-Chlorizidine A Targets Proteins within the Glycolytic Pathway.In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity.Glucose conjugation for the specific targeting and treatment of cancer.Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffoldsDefinition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target.Small-molecule inhibitors of human LDH5.Mini-review on glycolysis and cancer.Proteomics and metabolomics in cancer drug development.Tumor glycolysis as a target for cancer therapy: progress and prospects.Dysregulated glycolysis as an oncogenic event.Grubbs cross-metathesis pathway for a scalable synthesis of γ-keto-α,β-unsaturated esters.The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?Trienamine catalyzed asymmetric synthesis and biological investigation of a cytochalasin B-inspired compound collection.Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines.Piper and Vismia species from Colombian Amazonia differentially affect cell proliferation of hepatocarcinoma cells.Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death.Vessel pruning or healing: endothelial metabolism as a novel target?Anticancer agents interacting with membrane glucose transporters.Cancer cell bioenergetics and pH regulation influence breast cancer cell resistance to paclitaxel and doxorubicin.Phenylpropanoids and flavonoids from Phlomis kurdica as inhibitors of human lactate dehydrogenase.Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells.In vitro effects of some flavones on human pyruvate kinase isoenzyme M2.Carnosine: can understanding its actions on energy metabolism and protein homeostasis inform its therapeutic potential?Angiogenesis. Targeting vascular sprouts.Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors.Immune by Heart: Unexpected Observations Inspiring Perspective Therapeutic/Preventive Strategies against Cancer.Endothelial Cell Metabolism.Development and validation of a docking-based virtual screening platform for the identification of new lactate dehydrogenase inhibitors.A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by Using a Pharmacophore-based Approach.Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy.
P2860
Q26783189-D3A1B489-0C02-4137-95E9-2518B739749EQ27683724-EBDD799F-A9F3-4E10-AC50-C518A10DAC5EQ27693375-3486C8A7-2427-4F34-8B9B-3610B69A3586Q33872509-1FA2C2D9-6FBD-4C2A-8200-F60AD354BC04Q34503166-DD6C8036-A5D2-4371-9A39-8BFD2998B2C0Q34577887-BDA079D1-A696-4168-939D-5418F59BB426Q35836244-549025A7-F840-424A-9ABB-42E0F2874D8AQ35957729-F98B93E6-39AD-4B6D-ACBD-CB1A131C1A67Q36192530-9A031F0C-0FCC-4D93-A293-C7C919A5F27BQ36551125-519F6458-34C9-429F-B12B-1369510711D9Q36808494-44D053B7-EFA2-4C9D-96AF-7F701DDD3C4BQ37044525-B80ED984-40AB-4DBB-A861-E2FBE8EC26CFQ37200539-B2916242-781C-4E34-8485-5BAF714520E0Q37310087-5DEADB86-0DAA-40D8-ACAB-DCF51E7E10FFQ37371960-4E91E3A3-EE96-47DA-AD7F-E0E1AC1B66E6Q37634356-C572B202-EF12-42CD-B849-B84DE2693347Q38111291-8269D2E6-1F44-4290-98A8-5BFF9432AEA4Q38151765-2AFDF254-D68F-4F1A-8BEC-A4DAA6DB749EQ38168262-177820B2-A141-44F6-AB58-82A1885A44C2Q38327525-FE14CE11-06F0-4BD2-B7ED-CF8F86302130Q38451204-2F9F276F-0FB6-439C-8CC3-44ACA39B6143Q38612793-1A331993-3BEC-4234-ADB4-F96EF351DA98Q38623792-CCBA11BF-E685-4ED8-BE2E-5652DFDDDBAAQ38915783-1E09C49E-9EC5-4903-A4A3-BEF3FDF8BAE0Q38923260-EDDEEFEC-B1C1-4D4E-B2FB-FF31610B857EQ38943330-F3B610EB-D897-4E85-A205-5F428D9FB474Q39024164-C538FE55-B9DC-4224-8DEC-22B8C9D0D192Q39064468-513388DE-CE21-41E2-904C-31536336FF7FQ39132859-5EF02072-A915-4071-B5D6-F11E77A7175FQ41044824-13A9822B-B52A-45F0-A5F8-6553AE7307D6Q41701853-FEA3C90B-071F-4AB7-9BF7-9E65DE1AF8D0Q42703650-107AF429-5B32-4E37-8990-6B9CE0ECF1BEQ43225017-2157C874-7D17-490C-AD22-B986C138B1C6Q46299765-D461E2D8-860F-4D62-AAB8-E0DE8B43AEEAQ47298513-E7F13717-B86A-43E8-AC9B-7451EE1FDD5CQ47379404-0AE63641-4BB6-48B0-9102-A5043FE4C257Q49787990-6105B5DE-F8C7-490B-A91F-0015961608D2Q50975325-05E333C6-1367-4A2C-AFD0-B60BEE43B952Q53745043-1C7A0796-9050-4EF7-87AB-FA528976A3E1Q55456951-4D8B4608-2ECE-4CC8-A12C-C10601C94844
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Anticancer agents that counteract tumor glycolysis.
@ast
Anticancer agents that counteract tumor glycolysis.
@en
type
label
Anticancer agents that counteract tumor glycolysis.
@ast
Anticancer agents that counteract tumor glycolysis.
@en
prefLabel
Anticancer agents that counteract tumor glycolysis.
@ast
Anticancer agents that counteract tumor glycolysis.
@en
P2860
P356
P1433
P1476
Anticancer agents that counteract tumor glycolysis
@en
P2093
Carlotta Granchi
Filippo Minutolo
P2860
P304
P356
10.1002/CMDC.201200176
P577
2012-06-08T00:00:00Z